Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Oct 27;10(10):639-644.
doi: 10.4254/wjh.v10.i10.639.

European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift

Véronique Loustaud-Ratti  1 , Marilyne Debette-Gratien  2 , Paul Carrier  2
Affiliations
Editorial

European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift

Véronique Loustaud-Ratti et al. World J Hepatol. .

Abstract

The latest Association Française pour l'Etude du Foie - French Association for Study of the Liver (AFEF) and European Association for the Study of the Liver (EASL) recommendations announce a change of paradigm, for the management of patients infected with hepatitis C virus (HCV). The AFEF recommendations focus on the elimination of HCV infection on a national level by preventing reinfection, in less than ten years. This goal involves the facilitation of patients' management in a simplified pathway by increasing screening procedures and access to pangenotypic treatments mainly in the "reservoir" population of people who inject drugs and migrants. Even in the complex pathway of patients with previous comorbidities, AFEF takes the option of a therapeutic simplification. The EASL guidelines position themselves on the state of the art with a precise description of all therapeutic options available, without separating simplified and complex pathways even if they take into account the epidemiological evolution of difficult-to-treat populations.

Keywords: Direct acting antiviral drugs; Eradication; European; French; Guidelines; Hepatitis C; Migrants; Pangenotypic; People who inject drugs.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: Dr. Loustaud-Ratti reports personal fees from GILEAD, personal fees from MSD, personal fees from ABBVIE, grants and personal fees from BMS, outside the submitted work.

Similar articles

See all similar articles

Cited by

References

    1. European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. [cited July 11 2018] Available from: http://www.easl.eu/research/our-contributions/clinical-practice-guidelin.... - PubMed
    1. AFEF. Recommandations Textes Officiels: Recommandations. [cited July 11 2018] Available from: http://www.afef.asso.fr/RECOMMANDATIONS/recommandations_1.
    1. Pioche C, Pelat C, Larsen C, Desenclos JC, Jauffret-Roustide M, Lot F, Pillonel J, Brouardet C. Estimation de la prévalence de l’hépatite C en population générale, France métropolitaine, 2011. Bull Epidémiol Hebd. 2016;(13-14):224–229.
    1. Brutel C. 2014. Les immigrés récemment arrivés en France. INSEE Première. Available from: https://www.insee.fr/fr/statistiques/1281393.
    1. Comité Scientifique de l’étude HEPCORT. Premiers résultats: Prévalence de l’hépatite C en médecine de ville pour les patients sous TSO. Available from: https://www.rvh-synergie.org/prises-en-charge-des-addictions/penser-ense....

Publication types